News Channels

26 Oct 2020 Allergy Therapeutics announces start of innovative exploratory field study to evaluate efficacy and safety of Grass MATA MPL
26 Oct 2020 Novartis presents promising interim Phase II data of potential first-in-class oral therapy iptacopan (LNP023) in rare renal disease C3 glomerulopathy (C3G)
26 Oct 2020 Bayer acquires Asklepios BioPharmaceutical to broaden innovation base in cell and gene therapy
25 Oct 2020 Aileron Therapeutics Announces Proof-of-Concept Clinical Data from Ongoing ALRN-6924 Phase 1b Trial Presented in Late-Breaking Presentation at the EORTC-NCI-AACR Annual Symposium
25 Oct 2020 Revolution Medicines Reports Progress and Expansion of Combination Strategy with RMC-4630 as Therapeutic Backbone for RAS-Addicted Cancers
25 Oct 2020 Turning Point Therapeutics Presents Initial Clinical Data From Phase 1 SHIELD-1 Study of Novel MET/SRC/CSF1R Inhibitor TPX-0022 at 2020 EORTC-NCI-AACR Symposium
25 Oct 2020 BiondVax Announces Topline Results from Phase 3 Clinical Trial of the M-001 Universal Influenza Vaccine Candidate
25 Oct 2020 Syros Presents Initial Data from Phase 1 Clinical Trial of SY-5609, Its Selective Oral CDK7 Inhibitor, at EORTC-NCI-AACR Meeting
25 Oct 2020 FDA authorises restart of the COVID-19 AZD1222 vaccine US Phase III trial
25 Oct 2020 Farxiga DAPA-CKD Phase III trial reduced worsening of kidney function, risk of cardiovascular or renal death in patients with chronic kidney disease, irrespective of underlying cause
25 Oct 2020 Finerenone significantly reduced renal and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes
23 Oct 2020 Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy
23 Oct 2020 Arixa Pharmaceuticals Announces Acquisition by Pfizer’s Hospital Business
23 Oct 2020 Adicet Announces FDA Clearance of IND Application for First-in-Class Allogeneic CAR Gamma-Delta T Cell Therapy
23 Oct 2020 Galera Therapeutics Announces Dosing of First Patient in the Phase 1/2 GRECO-1 Clinical Trial of GC4711 in Combination with SBRT for Non-Small Cell Lung Cancer
23 Oct 2020 Homology Medicines Unveils New In Vivo Gene Therapy Development Program for Hunter Syndrome
23 Oct 2020 Retrophin Announces Agreement to Acquire Orphan Technologies
23 Oct 2020 First patient dosed in monalizumab Phase 3 clinical trial triggers $50M payment from AstraZeneca
23 Oct 2020 IAVI, Merck, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access
23 Oct 2020 LEO Pharma Announces U.S. FDA Approval for Enstilar® (calcipotriene and betamethasone dipropionate) Foam U.S. Prescribing Information Update to Include Data in Long-term Use in Plaque Psoriasis Treatment

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up